MORR F Lipid Solution 3% Intas Pharmaceuticals — Research Summary
MORR F Lipid Solution 3% Intas Pharmaceuticals is a pharmaceutical-grade 5-alpha reductase inhibitor formulated for laboratory research applications. This liquid preparation contains finasteride as the active pharmaceutical ingredient, manufactured by Intas Pharmaceuticals to clinical standards. Researchers at Stroid UK Shop can examine this compound’s mechanisms in hormonal pathway studies, particularly its selective inhibition of 5-alpha reductase type II enzyme systems. The topical solution format enables precise dosing control in experimental protocols while maintaining compound stability throughout research protocols.
Laboratory Applications
Research scientists investigate MORR F solution in studies examining dihydrotestosterone synthesis pathways and androgen metabolism mechanisms. The compound’s mechanism involves competitive inhibition of 5-alpha reductase, preventing conversion of testosterone to its more potent dihydrotestosterone metabolite. Laboratory studies typically evaluate concentration-response relationships in cell culture models and enzyme kinetics assays. Researchers specialising in aromatase inhibitors and finasteride formulations analyse this solution’s effects on hormonal balance parameters and receptor binding affinities. Advanced research protocols may examine combination effects with other modulators available through SARMs or peptides research programmes.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Finasteride |
| Concentration | 3% w/v |
| Manufacturer | Intas Pharmaceuticals |
| Form | Topical liquid solution |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.55 g/mol |
| Storage | Room temperature, protect from light |
Research Compliance
This product is manufactured by Intas Pharmaceuticals exclusively for in-vitro laboratory research and analytical purposes. MORR F Lipid Solution 3% is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate handling procedures and documentation compliance with institutional research protocols when studying this compound.
